We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and Eu... MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union. Show more
- Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented in an oral session at the American Academy of Oral Medicine 2024 annual meeting (AAOM) April 17-20...
LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company...
- Company aligned with FDA on requirements for ongoing Phase 2 AQUAx2 clinical trial for Grade 2/3 radiation-induced xerostomia to be considered pivotal supporting potential BLA filing - Company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.56 | 10.8737864078 | 5.15 | 5.92 | 5.07 | 159781 | 5.54442738 | CS |
4 | 0.56 | 10.8737864078 | 5.15 | 5.92 | 4.68 | 129641 | 5.17400051 | CS |
12 | -0.18 | -3.05602716469 | 5.89 | 6.85 | 4.68 | 145097 | 5.68503807 | CS |
26 | 0.1 | 1.7825311943 | 5.61 | 7.6 | 4.32 | 200558 | 5.89797715 | CS |
52 | -1.79 | -23.8666666667 | 7.5 | 8.35 | 3.49 | 216047 | 5.56948446 | CS |
156 | -7.53 | -56.8731117825 | 13.24 | 24.8948 | 3.49 | 185173 | 9.86920356 | CS |
260 | -17.63 | -75.5355612682 | 23.34 | 30.23 | 3.49 | 166804 | 12.2523775 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions